Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVATE: Actonel Persistence in GIO
NCT00616694Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in glucocorticoid-induced osteoporosis (GIOP), sponsored by Sanofi. Started Jul 2002; status: completed.
02
Drugs
risedronate
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT00616694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616694.